Onesource Specialty Pharma Limited has informed the Exchange regarding 'Disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers)Regulations, 2011 and Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.Promoter entity (Tenshi Pharmaceuticals Private Limited), has purchased 200,000 equity shares of OneSource Specialty Pharma Limited, from the market, on January 28, 2026.'.
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tenshi Pharmaceuticals Private Limited, a promoter entity of OneSource Specialty Pharma Limited, bought 200,000 equity shares from the open market on January 28, 2026. The transaction was disclosed under SEBI's Takeover Regulations and Insider Trading Regulations. The filing indicates continued promoter confidence through a market purchase rather than a private deal.
Promoter buying from the open market is generally viewed positively by retail investors as it signals insider confidence in the company's prospects. The relatively small size of 200,000 shares may have a limited direct impact on share price but reinforces promoter commitment.